DarioHealth Corp. (DRIO)

DarioHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	19.04	20.35	27.66	20.51	7.58	7.56
Revenue Growth (YoY)	-28.58%	-26.41%	34.82%	170.76%	0.22%	2.23%
Cost of Revenue	13.8	14.37	18	16.55	5.06	4.96
Gross Profit	5.25	5.98	9.66	3.96	2.51	2.6
Selling, General & Admin	45.16	41.93	46.82	63.24	27.98	16.61
Research & Development	21.73	20.25	19.65	17.22	4.43	3.69
Operating Expenses	66.88	62.17	66.47	80.46	32.42	20.3
Operating Income	-61.64	-56.19	-56.81	-76.49	-29.9	-17.71
Other Expense / Income	-5.93	3.17	5.38	0.24	-0.46	0.03
Pretax Income	-55.71	-59.36	-62.19	-76.73	-29.45	-17.74
Income Tax	-1.93	0.06	0	0.03	0	0
Net Income	-53.78	-59.43	-62.19	-76.76	-29.45	-17.74
Preferred Dividends	6.12	4.08	1.64	2.01	3.66	3.16
Net Income Common	-59.9	-63.51	-63.84	-78.77	-33.1	-20.89
Shares Outstanding (Basic)	34	28	24	17	6	2
Shares Outstanding (Diluted)	34	28	24	17	6	2
Shares Change	24.93%	20.04%	42.45%	178.23%	163.15%	93.58%
EPS (Basic)	-1.68	-1.93	-2.54	-4.07	-4.01	-8.00
EPS (Diluted)	-1.68	-1.93	-2.54	-4.07	-4.01	-8.00
Free Cash Flow	-39.3	-30.96	-48.29	-50.67	-17.85	-15.82
Free Cash Flow Per Share	-1.14	-1.09	-2.04	-3.05	-2.99	-6.98
Gross Margin	27.56%	29.40%	34.91%	19.32%	33.17%	34.36%
Operating Margin	-323.65%	-276.09%	-205.42%	-372.90%	-394.71%	-234.22%
Profit Margin	-314.51%	-312.06%	-230.82%	-383.98%	-436.95%	-276.37%
Free Cash Flow Margin	-206.35%	-152.14%	-174.60%	-247.01%	-235.67%	-209.33%
EBITDA	-50.61	-54.38	-57.47	-72.27	-29.26	-17.55
EBITDA Margin	-265.73%	-267.19%	-207.81%	-352.32%	-386.15%	-232.21%
Depreciation & Amortization	5.1	4.99	4.72	4.46	0.19	0.18
EBIT	-55.71	-59.36	-62.19	-76.73	-29.45	-17.74
EBIT Margin	-292.52%	-291.68%	-224.87%	-374.05%	-388.66%	-234.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).